Core Scientific (NASDAQ:CORZ) Stock Rating Upgraded by Needham & Company LLC

Core Scientific (NASDAQ:CORZ) was upgraded by investment analysts at Needham & Company LLC from a “hold” rating to a “buy” rating in a report released on Tuesday, MarketBeat.com reports. The brokerage presently has a $23.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 45.20% from the stock’s previous close.

Other equities analysts have also issued reports about the company. Citigroup raised Core Scientific from a “market perform” rating to an “outperform” rating in a report on Thursday, December 18th. Citizens Jmp upgraded Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price objective for the company in a research note on Thursday, December 18th. Keefe, Bruyette & Woods raised their target price on Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a research report on Tuesday, January 27th. BTIG Research upgraded Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 target price on the stock in a research note on Tuesday, January 6th. Finally, HC Wainwright restated a “buy” rating and set a $25.00 price target on shares of Core Scientific in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Core Scientific presently has an average rating of “Moderate Buy” and an average target price of $24.84.

Core Scientific Price Performance

Shares of CORZ stock opened at $15.84 on Tuesday. The firm has a 50-day moving average of $17.28 and a 200-day moving average of $16.96. The company has a market cap of $4.99 billion, a P/E ratio of 13.54 and a beta of 6.87. Core Scientific has a one year low of $6.20 and a one year high of $23.63.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.69. The firm had revenue of $79.76 million for the quarter, compared to analysts’ expectations of $118.45 million. During the same quarter last year, the firm posted ($0.69) earnings per share. The firm’s revenue for the quarter was down 16.0% compared to the same quarter last year. As a group, research analysts expect that Core Scientific will post 0.52 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Core Scientific

Several large investors have recently added to or reduced their stakes in the company. Allworth Financial LP raised its stake in Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after acquiring an additional 950 shares during the period. Larson Financial Group LLC boosted its position in Core Scientific by 936.7% during the fourth quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after purchasing an additional 1,686 shares during the period. HHM Wealth Advisors LLC increased its stake in shares of Core Scientific by 96.5% in the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock worth $33,000 after purchasing an additional 946 shares in the last quarter. Osaic Holdings Inc. raised its position in shares of Core Scientific by 112.1% in the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after purchasing an additional 1,066 shares during the period. Finally, Danske Bank A S bought a new stake in shares of Core Scientific in the fourth quarter valued at approximately $36,000.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Multiple analyst upgrades/raises reinforce bullish expectations — Canaccord raised its target to $20 and kept a Buy rating, Needham upgraded to Buy with a $23 target, and HC Wainwright reaffirmed Buy at $25, signaling institutional conviction in the AI pivot and creating upside narrative for the stock. Canaccord Raise
• Positive Sentiment: Colocation (AI) revenue is accelerating — company reports show colocation revenue surged ~268% YoY, driven by contracts such as CoreWeave; that growth supports the strategic shift from Bitcoin mining toward higher-margin AI services. Colocation Revenue Surge
• Positive Sentiment: CoreWeave deal progressing ahead of schedule — management commentary and press pieces note the CoreWeave relationship is on track, supporting near-term colocation revenue visibility. CoreWeave Ahead of Schedule
• Positive Sentiment: Large call-option activity suggests speculative/bullish positioning — unusually high call volume (≈188,642 calls) indicates investors are placing leveraged bullish bets ahead of anticipated upside from the AI pivot.
• Neutral Sentiment: MarketBeat / analysis pieces argue a long-term, multi-billion backlog tied to AI colocation could unlock large upside, but these are thesis pieces rather than new company disclosures; useful for framing upside but dependent on execution. MarketBeat AI Thesis
• Neutral Sentiment: Short-interest entries in the feed show anomalous/zero values (likely reporting noise) and do not provide actionable short-seller signal at this time.
• Negative Sentiment: Top-line weakness and volatility in earnings — Q4 results showed a sharp revenue decline (reports cite ~38% YoY drop) and a revenue miss versus consensus, and management flagged negative adjusted EBITDA tied to the transition/expansion which pressured sentiment and drove intraday weakness after the release. Q4 Revenue Fall
• Negative Sentiment: Near-term sell-side caution and price action — media and market coverage noted a material stock pullback (one headline cited a ~14% drop after the pivot/earnings), reflecting investor concern about execution risk, cash burn for expansion, and balance-sheet pressure. Stock Drop After Pivot

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.